Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/106096
Title: | Microbial BMAA and the Pathway for Parkinson's Disease Neurodegeneration | Authors: | Nunes-Costa, Daniela Magalhães, João Duarte G-Fernandes, Maria Cardoso, Sandra Morais Empadinhas, Nuno |
Keywords: | Parkinson’s disease; mitochondrial dysfunction; innate immunity; neurodegeneration; microbial b-Nmethylamino- L-alanine (BMAA) | Issue Date: | 2020 | Publisher: | Frontiers Media S.A. | Project: | POCI-01-0145-FEDER-030712 CENTRO-01-0145-FEDER-000012- HealthyAging2020) info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID/NEU/04539/2019/PT SFRH/BD/117777/2016 PD/BD/146409/2019 |
metadata.degois.publication.title: | Frontiers in Aging Neuroscience | metadata.degois.publication.volume: | 12 | Abstract: | The neurotoxin β-N-methylamino-L-alanine (BMAA) is a natural non-proteinogenic diamino acid produced by several species of both prokaryotic (cyanobacteria) and eukaryotic (diatoms and dinoflagellates) microorganisms. BMAA has been shown to biomagnify through the food chain in some ecosystems, accumulating for example in seafood such as shellfish and fish, common dietary sources of BMAA whose ingestion may have possible neuronal consequences. In addition to its excitotoxic potential, BMAA has been implicated in protein misfolding and aggregation, inhibition of specific enzymes and neuroinflammation, all hallmark features of neurodegenerative diseases. However, the exact molecular mechanisms of neurotoxicity remain to be elucidated in detail. Although BMAA is commonly detected in its free form, complex BMAA-containing molecules have also been identified such as the paenilamicins, produced by an insect gut bacterial pathogen. On the other hand, production of BMAA or BMAA-containing molecules by members of the human gut microbiota, for example by non-photosynthetic cyanobacteria, the Melainabacteria, remains only hypothetical. In any case, should BMAA reach the gut it may interact with cells of the mucosal immune system and neurons of the enteric nervous system (ENS) and possibly target the mitochondria. Here, we review the available evidence and hint on possible mechanisms by which chronic exposure to dietary sources of this microbial neurotoxin may drive protein misfolding and mitochondrial dysfunction with concomitant activation of innate immune responses, chronic low-grade gut inflammation, and ultimately the neurodegenerative features observed across the gut-brain axis in Parkinson's disease (PD). | URI: | https://hdl.handle.net/10316/106096 | ISSN: | 1663-4365 | DOI: | 10.3389/fnagi.2020.00026 | Rights: | openAccess |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais IIIUC - Artigos em Revistas Internacionais FMUC Medicina - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
fnagi-12-00026.pdf | 1.23 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
51
checked on Aug 26, 2024
WEB OF SCIENCETM
Citations
50
checked on Sep 2, 2024
Page view(s)
102
checked on Oct 30, 2024
Download(s)
51
checked on Oct 30, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License